Procter & Gamble Health Limited (NSE:PGHL)
India · Delayed Price · Currency is INR 6,630.00
+128.00 (1.97%)
Jul 31, 2026, 3:29 PM IST
Procter & Gamble Health Market Cap
Procter & Gamble Health has a market cap or net worth of 109.51 billion as of July 31, 2026. Its market cap has increased by 10.88% in one year.
Market Cap
109.51B
Enterprise Value
107.75B
Revenue
14.08B
Ranking
n/a
PE Ratio
33.50
Stock Price
6,630.00
ChartMarket Cap Chart
Since June 14, 1999, Procter & Gamble Health's market cap has increased from 9.75B to 109.51B, an increase of 1,023.70%. That is a compound annual growth rate of 9.32%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 109.51B | 15.72% |
| Dec 31, 2025 | 94.63B | 8.85% |
| Dec 31, 2024 | 86.94B | 5.90% |
| Dec 29, 2023 | 82.10B | 23.12% |
| Dec 30, 2022 | 66.69B | -24.14% |
| Dec 31, 2021 | 87.91B | -22.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 187.72B |
| NATCO Pharma | 164.24B |
| Cohance Lifesciences | 162.61B |
| Alembic Pharmaceuticals | 156.67B |
| Alivus Life Sciences | 142.38B |
| Akums Drugs and Pharmaceuticals | 100.79B |
| Sudeep Pharma | 99.51B |
| Strides Pharma Science | 94.48B |